Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Background Patients with cardiovascular diseases (CVD) are at high risk of experiencing drug–drug interactions (DDIs). The objective of this study was to evaluate the frequency, level and risk factors associated with potential-DDIs (pDDIs) in hospitalized CVD patients at cardiology departments of tw...
Main Authors: | Zarka Akbar, Sundas Rehman, Asad Khan, Amjad Khan, Muhammad Atif, Nafees Ahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | http://dx.doi.org/10.1186/s40545-021-00348-1 |
Similar Items
-
Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital
by: Gracia Santos-Díaz, et al.
Published: (2020-07-01) -
Prevalence of potential drug–drug interactions with disease‐specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study
by: Puck N. Norell, et al.
Published: (2022-07-01) -
Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
by: Quentin Delbaere, et al.
Published: (2023-01-01) -
Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
by: Asif Massud, et al.
Published: (2022-06-01) -
Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice
by: Stephan R. Künzel, et al.
Published: (2023-09-01)